[
  {
    "ts": null,
    "headline": "Assessing Medtronic (MDT) Valuation After Mixed Recent Share Performance",
    "summary": "Medtronic stock at a glance after recent performance Medtronic (MDT) has seen a 0.4% gain over the past day, while returns over the past week, month, and past 3 months have been negative, creating a mixed backdrop for investors. See our latest analysis for Medtronic. Putting that in context, Medtronic’s 1 year total shareholder return of 10.3% contrasts with a small 1 year to date share price gain of 1%. This suggests recent momentum has cooled after stronger returns when dividends are...",
    "url": "https://finnhub.io/api/news?id=8b3d30c699c60b467eaea1c6b35eae25fd38149ca2ed8d6b586e8a6929821efd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772212686,
      "headline": "Assessing Medtronic (MDT) Valuation After Mixed Recent Share Performance",
      "id": 139254485,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Medtronic stock at a glance after recent performance Medtronic (MDT) has seen a 0.4% gain over the past day, while returns over the past week, month, and past 3 months have been negative, creating a mixed backdrop for investors. See our latest analysis for Medtronic. Putting that in context, Medtronic’s 1 year total shareholder return of 10.3% contrasts with a small 1 year to date share price gain of 1%. This suggests recent momentum has cooled after stronger returns when dividends are...",
      "url": "https://finnhub.io/api/news?id=8b3d30c699c60b467eaea1c6b35eae25fd38149ca2ed8d6b586e8a6929821efd"
    }
  },
  {
    "ts": null,
    "headline": "LeMaitre Vascular: The Compounder Keeps Compounding",
    "summary": "LeMaitre Vascular: The Compounder Keeps Compounding",
    "url": "https://finnhub.io/api/news?id=d06ba0acf5f2c1ca3aaf52d02bfa6d0ac9345633300e8914ed263399c09b330a",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772204486,
      "headline": "LeMaitre Vascular: The Compounder Keeps Compounding",
      "id": 139255897,
      "image": "",
      "related": "MDT",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=d06ba0acf5f2c1ca3aaf52d02bfa6d0ac9345633300e8914ed263399c09b330a"
    }
  },
  {
    "ts": null,
    "headline": "Best Dividend Aristocrats For March 2026",
    "summary": "NOBL is up 9.39% YTD vs SPYâs 1.08% as Dividend Aristocrats rebound in 2026.",
    "url": "https://finnhub.io/api/news?id=c0fc60f021ba8668f89aa3a46f7b3fd9afaf3313c8e3b9b8155c6a4d110db360",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772194865,
      "headline": "Best Dividend Aristocrats For March 2026",
      "id": 139252799,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2209914068/image_2209914068.jpg?io=getty-c-w1536",
      "related": "MDT",
      "source": "SeekingAlpha",
      "summary": "NOBL is up 9.39% YTD vs SPYâs 1.08% as Dividend Aristocrats rebound in 2026.",
      "url": "https://finnhub.io/api/news?id=c0fc60f021ba8668f89aa3a46f7b3fd9afaf3313c8e3b9b8155c6a4d110db360"
    }
  }
]